GlassScriptPhysician profile
Haleh Ebrahimi
NPI 1386909703
$5,780.00
in general payments reported to CMS, 2019-2025
17 companies · $718 in 2025
The $718 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.42 · 2020: $17.91 · 2021: $244 · 2022: $3,286 · 2023: $779 · 2024: $721 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,191 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,191.39 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $2,743.08 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $1,019.32 | 2021-2025 | Acuvue |
| Alcon Vision LLC | $540.07 | 2019-2025 | Precision7, Total30 |
| Visioneering Technologies, INC. | $318.67 | 2024 | |
| Rxsight INC | $152.77 | 2022-2024 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Bausch & Lomb Americas INC. | $140.69 | 2023-2024 | Lotemax Sm, Vyzulta, Prolensa |
| Tarsus Pharmaceuticals, INC. | $123.06 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $118.39 | 2022 | |
| Biotissue Holdings INC. | $117.17 | 2022 | |
| Abbvie INC. | $112.87 | 2022-2023 | Durysta, Alphagan P, Lumigan |
| Novartis Pharmaceuticals Corporation | $105.76 | 2021-2023 | |
| Oyster Point Pharma, INC. | $69.65 | 2022-2023 | Tyrvaya |
| Synergeyes, INC. | $66.06 | 2021 | |
| Horizon Therapeutics Plc | $60.63 | 2022 | |
| Thea Pharma INC. | $37.86 | 2022-2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.18 | 2021 | |
| Harrow Eye, LLC | $20.77 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haleh Ebrahimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.